Controlled release

控释
  • 文章类型: Journal Article
    与目前的临床黄金标准系统性免疫抑制相比,用于局部免疫调节的药物递送策略具有巨大的前景,因为它们可以提高挽救生命或增强生命的移植的风险比。这样的策略在较低药物剂量的动物模型中促进了延长的移植物存活,同时使脱靶效应最小化。尽管在临床前动物研究中取得了有希望的结果,这些策略向临床试验的进展面临挑战.对翻译障碍的全面了解是临床验证有效的免疫调节药物递送方案的关键的第一步,该方案在临床前动物模型中被证明具有安全性和耐受性。这篇综述概述了移植局部免疫调节策略的最新技术,并概述了阻碍其临床转化的关键挑战。
    Drug delivery strategies for local immunomodulation hold tremendous promise compared to current clinical gold-standard systemic immunosuppression as they could improve the benefit to risk ratio of life-saving or life-enhancing transplants. Such strategies have facilitated prolonged graft survival in animal models at lower drug doses while minimizing off-target effects. Despite the promising outcomes in preclinical animal studies, progression of these strategies to clinical trials has faced challenges. A comprehensive understanding of the translational barriers is a critical first step towards clinical validation of effective immunomodulatory drug delivery protocols proven for safety and tolerability in pre-clinical animal models. This review overviews the current state-of-the-art in local immunomodulatory strategies for transplantation and outlines the key challenges hindering their clinical translation.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    基于水凝胶的储库通常倾向于在注射的地方保留并且具有优异的生物相容性,但在控制药物释放方面相对较差。纳米颗粒(NP)通常具有相反的性质。NP越小,他们离开注射部位的可能性就越大。它们的生物相容性根据材料而变化,但可能较差。然而,NPs可以很好地控制药物释放。在这些和其他属性中,结合NP和水凝胶可以利用它们的优点并消除它们的缺点。这篇综述强调了混合NP-水凝胶系统在药物递送中的基本原理,生产它们的基本方法,以及将两个系统结合起来解决特定问题的示例。
    Hydrogel-based depots typically tend to remain where injected and have excellent biocompatibility but are relatively poor at controlling drug release. Nanoparticles (NPs) typically have the opposite properties. The smaller the NPs are, the more likely they are to leave the site of injection. Their biocompatibility is variable depending on the material but can be poor. However, NPs can be good at controlling drug release. In these and other properties, combining NPs and hydrogels can leverage their advantages and negate their disadvantages. This review highlights the rationale for hybrid NP-hydrogel systems in drug delivery, the basic methods of producing them, and examples where combining the two systems addressed specific problems.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    近年来,生物聚合物纳米纤维作为活性生物可降解包装系统的发展受到了特别的关注。这项研究的目的是开发基于玉米醇溶蛋白的电纺纳米纤维(NFs),并掺入香叶醇负载的纳米脂质体(G负载的NLP)。香叶醇以79.23%的效率包封到NLP中。负载G的NLP的粒径和ζ电位为121.50nm和-38.30mV,分别。香叶醇在NLP中的成功负载通过傅里叶变换红外(FT-IR)光谱法获得批准。脂质体囊泡呈球形。以三种不同浓度(0.25、0.5和1%w/v)在基于玉米醇溶蛋白的电纺NF中添加G-负载的NLP。所有NFs样品均表现出原纤维结构。NLPs浓度的增加增强了NFs的热稳定性。然而,添加G负载的NLP不会改变玉米醇溶蛋白NFs的晶体结构。最高的表面疏水性与含有1%G-负载的NLP的NF相关。NFs的机械参数取决于NLP的浓度。掺入G负载的NLP的NFs对四种食源性致病菌(金黄色葡萄球菌,单核细胞增生李斯特菌,大肠杆菌,和鼠伤寒沙门氏菌)的抑制作用为4.5-22毫米。此外,NFs样品的α-二苯基-β-吡啶酰肼(DPPH)清除活性位于20%-48%的范围内。这些发现代表了负载G的NLP在作为活性包装材料的基于玉米醇溶蛋白的NF中用作生物活性化合物的效率。
    In recent years, development of biopolymeric nanofibers as an active biodegradable packaging system has attracted specific attention. The objective of this research was to develop zein-based electrospun nanofibers (NFs) incorporated with geraniol-loaded nanoliposomes (G-loaded NLPs). Geraniol was encapsulated into NLPs with an efficiency of 79.23%. The particle size and zeta potential of G-loaded NLPs were 121.50 nm and -38.30 mV, respectively. The successful loading of geraniol in the NLPs was approved by Fourier transform infrared (FT-IR) spectroscopy. The liposomal vesicles showed spherical shapes. G-loaded NLPs were added in the zein-based electrospun NFs at three different concentrations (0.25, 0.5, and 1%w/v). All NFs samples exhibited fibrillar structure. The increase of NLPs concentration enhanced the thermal stability of the NFs. However, the crystalline structure of zein NFs did not change by the addition of G-loaded NLPs. The highest surface hydrophobicity was related to the NFs containing 1% G-loaded NLPs. The mechanical parameters of NFs depend on the concentration of NLPs. The NFs incorporated with G-loaded NLPs showed inhibition activity against four foodborne pathogenic bacteria (Staphylococcus aureus, Listeria monocytogenes, Escherichia coli, and Salmonella typhimurium) with an inhibition zone of 4.5-22 mm. Moreover, the α-diphenyl-β-picrylhydrazyl (DPPH) scavenging activity of NFs samples was located at the range of 20%-48%. These findings represent the Efficiency of the G-loaded NLPs for use as bioactive compound in the zein-based NFs as an active packaging material.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    聚合物和药物科学的融合显著地具有先进的药物递送系统。碳水化合物聚合物,尤其是羧甲基化的,为药品提供多种好处。互穿聚合物网络(IPN)结合合成和天然聚合物以增强药物递送。该研究旨在使用羧甲基纤维素钠(SCMC)和羧甲基魔芋葡甘露聚糖(CMKGM)开发IPN珠,用于口服布洛芬(IB)后的控释。目标包括配方优化,物理化学性质的表征,评估pH依赖性溶胀和药物释放行为,以促进生物相容性和有效的口服药物递送系统。使用SEM分析珠子,FTIR,DSC,和XRD技术。使用不同比例的聚合物(CMKGM:SCMS)和交联剂浓度(2和4%w/v),显著影响珠子尺寸,肿胀,药物封装,和释放特性。DSC结果表明,与天然聚合物相比,IPN珠粒具有更高的热稳定性。XRD显示IB分散在聚合物基质内。IPN珠子尺寸范围为580±0.56至324±0.27μm,几乎是球形的。IPN珠在碱性条件(pH7.4)下显示连续释放,在酸性介质(pH1.2)中显示最小释放。这些发现表明,配制的IPN珠可以调节药物在酸性和碱性环境中的释放,可能减轻通常与口服IB相关的胃不良反应。
    The convergence of polymer and pharmaceutical sciences has advanced drug delivery systems significantly. Carbohydrate polymers, especially carboxymethylated ones, offer versatile benefits for pharmaceuticals. Interpenetrating polymer networks (IPNs) combine synthetic and natural polymers to enhance drug delivery. The study aims to develop IPN beads using sodium carboxymethyl cellulose (SCMC) and carboxymethyl konjac glucomannan (CMKGM) for controlled release of ibuprofen (IB) after oral administration. Objectives include formulation optimization, characterization of physicochemical properties, evaluation of pH-dependent swelling and drug release behaviors to advance biocompatible and efficient oral drug delivery systems. The beads were analyzed using SEM, FTIR, DSC, and XRD techniques. Different ratio of polymers (CMKGM:SCMS) and crosslinker concentrations (2&4 %w/v) were used, significantly impacting bead size, swelling, drug encapsulation, and release characteristics. DSC results indicated higher thermal stability in IPN beads compared to native polymers. XRD revealed IB dispersion within the polymer matrix. IPN beads size ranged from 580 ± 0.56 to 324 ± 0.27 μm, with a nearly spherical shape. IPN beads exhibited continuous release in alkaline conditions (pH 7.4) and minimal release in acidic media (pH 1.2). These findings suggest that the formulated IPN beads can modulate drug release in both acidic and alkaline environments, potentially mitigating the gastric adverse effects often associated with oral administration of IB.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    农药的新型纳米/微载体代表了可持续害虫管理的非常有前途的新领域。然而,尽管进行了广泛的实验室研究,关于野外应用纳米农药的设计和评估的研究很少。在这项研究中,我们提出了一种在油-水界面上超声辅助和氢键自组装的直接绿色合成方法,用于合成聚乳酸(PLA)微球,精确控制微球的大小。所得的负载CAP的PLA微球(CAP-PLAMS)在自然环境中表现出高的农药包封效率和稳定性。已确定非Fickian扩散主要控制农药释放,从而实现分子传输速度的动态控制。重要的是,我们的功能性CAP-PLAMS在实验室和现场条件下都表现出优异的持续农药释放性能,同时在控制O.方面保持了比正常CAP更好的杀虫效力。因此,我们建议我们的功能PLA微球可以作为理想的农药载体在持续治疗O.nubilalis中。
    New nano/microcarriers of pesticides represent a highly promising novel field for sustainable pest management. However, despite extensive laboratory research, few studies on the design and evaluation of nanopesticides for field applications exist. In this study, we present a straightforward and green synthetic method of ultrasonic-assisted and hydrogen-bonded self-assembly at the oil-water interface for the synthesis of polylactic acid (PLA) microspheres encapsulating chlorantraniliprole (CAP), with precise control over the size of the microspheres. The resulting CAP-loaded PLA microspheres (CAP-PLA MS) exhibit both high pesticide encapsulation efficiency and stability in natural environments. It has been determined that non-Fickian diffusion mainly controls pesticide release, thus enabling dynamic control over molecular transport speeds. Importantly, our functional CAP-PLA MS demonstrates superior sustained pesticide release performance under both laboratory and field conditions while maintaining better exceptional insecticidal efficacy than normal CAP in controlling O. nubilalis at a concentration of 30 or 45 g/ha. Consequently, we propose that our functional PLA microspheres could serve as ideal pesticide carriers in the sustained treatment of O. nubilalis.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    软骨在损伤后的自我修复受到严重限制,组织工程支架移植被认为是最有前途的软骨再生策略。然而,没有细胞和生长因子的支架,这可以有效避免长的细胞培养时间,感染风险高,对污染的敏感性,保持稀缺。因此,我们开发了一种细胞和生长因子双重游离分层结构的纳米纤维海绵来模拟细胞外基质,其中包封的核-壳纳米纤维既用作机械载体又用作生物活性生物质分子(硫酸葡糖胺)的持久载体。在这种设计的海绵中纳米纤维的保护下,硫酸氨基葡萄糖可以连续释放至少30天,在大鼠软骨缺损模型中,显着加速了软骨组织的修复。此外,以羧甲基壳聚糖为骨架的纳米纤维海绵能有效填充不规则软骨缺损,适应软骨运动过程中的动态变化,即使在多次压缩循环后,也能保持几乎100%的弹性。这一战略,它结合了纤维冷冻成型技术和控释方法来封装生物活性,允许组装具有分层纳米纤维结构的多孔仿生支架,提供了一种新颖安全的组织修复方法。
    Cartilage is severely limited in self-repair after damage, and tissue engineering scaffold transplantation is considered the most promising strategy for cartilage regeneration. However, scaffolds without cells and growth factors, which can effectively avoid long cell culture times, high risk of infection, and susceptibility to contamination, remain scarce. Hence, we developed a cell- and growth factor-dual free hierarchically structured nanofibrous sponge to mimic the extracellular matrix, in which the encapsulated core-shell nanofibers served both as mechanical supports and as long-lasting carriers for bioactive biomass molecules (glucosamine sulfate). Under the protection of the nanofibers in this designed sponge, glucosamine sulfate could be released continuously for at least 30 days, which significantly accelerated the repair of cartilage tissue in a rat cartilage defect model. Moreover, the nanofibrous sponge based on carboxymethyl chitosan as the framework could effectively fill irregular cartilage defects, adapt to the dynamic changes during cartilage movement, and maintain almost 100 % elasticity even after multiple compression cycles. This strategy, which combines fiber freeze-shaping technology with a controlled-release method for encapsulating bioactivity, allows for the assembly of porous bionic scaffolds with hierarchical nanofiber structure, providing a novel and safe approach to tissue repair.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    花青素的不稳定性显著降低了其作为食物营养素的生物利用度。这项概念验证研究旨在开发花青素的有效载体以克服这一挑战。通过SEM(扫描电子显微镜)和流变学分析对水凝胶进行表征,揭示了典型凝胶结构的形成。MTT(甲基噻唑基四唑)和溶血试验证实它们具有较高的生物相容性。包封效率分析和荧光显微镜图像证明了通过pH响应水凝胶成功且有效地包封花青素。稳定性研究进一步验证了肽水凝胶在帮助花青素分子抵抗诸如胃酸,高温,和重金属。随后,在模拟胃(肠)液中的响应性研究表明,pH响应肽水凝胶可以保护花色苷分子免受胃酸的影响,同时在肠液环境中实现快速,完全的释放。这些结果表明,这些肽水凝胶可以稳定花青素并促进其控制释放,可能导致个性化的交付系统。
    The instability of anthocyanins significantly reduces their bioavailability as food nutrients. This proof-of-concept study aimed to develop efficient carriers for anthocyanins to overcome this challenge. Characterization of the hydrogels via SEM (scanning electron microscope) and rheological analysis revealed the formation of typical gel structures. MTT (methyl thiazolyl tetrazolium) and hemolysis assays confirmed that their high biocompatibility. Encapsulation efficiency analysis and fluorescence microscopy images demonstrated successful and efficient encapsulation of anthocyanins by pH-responsive hydrogels. Stability studies further validated the effect of peptide hydrogels in helping anthocyanin molecules withstand factors such as gastric acid, high temperatures, and heavy metals. Subsequently, responsive studies in simulated gastric (intestinal) fluid demonstrated that the pH-responsive peptide hydrogels could protect anthocyanin molecules from gastric acid while achieving rapid and complete release in intestinal fluid environments. These results indicate that these peptide hydrogels could stabilize anthocyanins and facilitate their controlled release, potentially leading to personalized delivery systems.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    目的:阿昔洛韦(ACY)用于治疗口服病毒性疱疹,但溶解度和生物利用度较低。硬脂酸(SA)是亲脂性的,可以与药物结合。因此,这项研究旨在表征SA纳米颗粒在增加口腔上皮细胞对ACY的细胞摄取方面的特性。假设是SA纳米颗粒增加ACY持续释放,是稳定的,增加药物摄取。
    方法:优化生产参数(超声处理的持续时间和幅度)以生产含SA的ACY的固体脂质纳米颗粒(SLN)。在不同储存条件(4°C和37°C持续1、15和45天)下表征颗粒稳定性。SLN进一步表征了它们的药代动力学特征,细胞毒性,体外通透性,以及调节基因表达和促进口腔上皮细胞吸收ACY的能力。
    结果:药代动力学研究显示ACY从SLN持续和扩散释放,与15分钟的初始爆发释放。储存45d后,在4°C和37°C下保持的SLN在120分钟时显示>90%的药物的最大释放。用SLN处理的细胞表现出明显高于ACY处理的细胞内药物含量,并且显着增加了TJP-1,OCLN的遗传表达,和ECAD。
    结论:该假设被接受,因为含有ACY的SA纳米颗粒可以维持药物递送并增强其在上皮细胞中的吸收。因此,SA纳米颗粒有望在治疗由HSV-1引起的口腔疱疹和其他感染中改善ACY摄取。
    OBJECTIVE: Acyclovir (ACY) is used to treat oral viral herpes but has low solubility and bioavailability. Stearic acid (SA) is lipophilic and can be combined with drugs. Therefore, this study aimed to characterize the properties of SA nanoparticles in increasing the cellular uptake of ACY by oral epithelial cells. The hypothesis was that SA nanoparticles increase sustained ACY release, are stable, and increase drug uptake.
    METHODS: The production parameters (duration and amplitude of sonication) were optimized to produce solid lipid nanoparticles (SLN) of SA-containing ACY. Particle stability was characterized under different storage conditions (4 °C and 37 °C for 1, 15, and 45 days). SLN were further characterized for their pharmacokinetic profile, cytotoxicity, in vitro permeability, and ability to modulate gene expression and promote ACY uptake by oral epithelial cells.
    RESULTS: Pharmacokinetic studies revealed sustained and diffusional release of ACY from the SLN, with an initial burst release of 15 min. After 45 d of storage, SLN kept at both 4 °C and 37 °C showed a maximum release of > 90 % of the drug at 120 min. Cells treated with SLN presented a significantly higher intracellular drug content than those treated with ACY and significantly increased the genetic expression of TJP-1, OCLN, and ECAD.
    CONCLUSIONS: The hypothesis was accepted as SA nanoparticles containing ACY can sustain drug delivery and enhance its absorption into epithelial cells. Therefore, SA nanoparticles are promising for improving ACY uptake in treating oral herpes and other infections caused by HSV-1.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    目的:我们通过溶胶-凝胶反应合成了MgONP,并研究了它们作为载体将Mg2递送到受影响的关节以治疗骨关节炎(OA)。材料与方法:用透射电子显微镜(TEM)表征样品的理化性质,动态光散射(DLS)和X射线衍射(XRD)。通过ICP-MS监测Mg2+的释放。使用MTT测定评价潜在的细胞毒性。在兔OA模型中评估功效和生物安全性。结果:MgONPs可以将Mg2+释放时间从0.5h延长至12h。当浓度低于250μg/ml时,没有观察到明显的细胞毒性。关节内样品能有效缓解软骨的退变和破坏。结论:本研究证明了MgONPs作为一种安全有效的治疗OA的潜力。同时,颗粒的大小可能在影响治疗结果中起重要作用。
    [方框:见正文]。
    Aim: We synthesized MgO NPs via sol-gel reaction and investigated them as carriers to deliver Mg2+ to the affected joint for osteoarthritis (OA). Materials & methods: The physicochemical properties of samples were characterized by transmission electron microscope (TEM), dynamic light scattering (DLS) and x-ray diffraction (XRD). The release of Mg2+ was monitored by ICP-MS. The potential cytotoxicity was evaluated using MTT assay. The efficacy and biosafety were evaluated in a rabbit OA model. Results: MgO NPs can prolong the Mg2+ release time from 0.5 h to 12 h. No significant cytotoxicity was observed when concentrations below 250 μg/ml. Intra-articular samples could effectively alleviate the degeneration and destruction of the cartilage. Conclusion: this study demonstrates the potential of MgO NPs as a safe and effective treatment of OA. Simultaneously, the size of the particles may play a significant role in influencing the therapeutic outcome.
    [Box: see text].
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    控释给药系统(CRDDS)比常规速释给药系统(IRDDS)更有利于减少摄入量,长时间的行动,副作用较小,更高的生物利用度,等。CRDDS的制备比IRDDS更复杂。热熔挤出(HME)技术用于开发水溶性差的药物的无定形固体分散体,以提高其溶出速率和口服生物利用度。HME可用于开发CRDDS。持续释放系统(SRDDS),通常口服,也可以使用HME开发。该技术具有不使用有机溶剂的优点,将结晶药物转化为无定形药物,提高生物利用度,等。然而,药物的热敏感性,药物-聚合物之间的混溶性,和一些聚合物的可用性是HME在开发CRDDS和SRDDS时面临的一些挑战。选择合适的聚合物和借助QbD原理优化工艺是HME成功应用的两个重要方面。在这次审查中,讨论了使用HME制备SRDDS和CRDDS的策略及其在研究中的应用。
    Controlled-release drug delivery systems (CRDDS) are more beneficial than conventional immediate release (IRDDS) for reduced intake, prolonged duration of action, lesser adverse effects, higher bioavailability, etc. The preparation of CRDDS is more complex than IRDDS. The hot melt extrusion (HME) technique is used for developing amorphous solid dispersion of poorly water soluble drugs to improve their dissolution rate and oral bioavailability. HME can be employed to develop CRDDS. Sustained release delivery systems (SRDDS), usually given orally, can also be developed using HME. This technique has the advantages of using no organic solvent, converting crystalline drugs to amorphous, improving bioavailability, etc. However, the heat sensitivity of drugs, miscibility between drug-polymer, and the availability of a few polymers are some of the challenges HME faces in developing CRDDS and SRDDS. The selection of a suitable polymer and the optimization of the process with the help of the QbD principle are two important aspects of the successful application of HME. In this review, strategies to prepare SRDDS and CRDDS using HME are discussed with its applications in research.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

公众号